MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Unit: Dollar
Positive Cash Flow Breakdown
Net income (loss)
Other current assets
Accounts payable, related party
Others
Negative Cash Flow Breakdown
Accounts receivable
Deferred revenue
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
250,242
240,979
-134,570
-225,902
Depreciation
741
1,054
2,297
5,396
Common stock issued for services
-
-
0
0
Stock-based compensation
21,095
23,344
23,360
21,127
Accounts receivable-Nonrelated Party
-
-
-
245,428
Accounts receivable
600,891
-49,242
32,013
-
Other current assets
-72,170
-69,346
-102,368
-121,905
Right-of-use asset
-13,536
-16,341
-16,049
187,408
Accounts payable-Nonrelated Party
-
-
-
215,723
Accounts payable
-170,828
118,902
-309,536
-
Accounts payable-Related Party
-
-
-
137,764
Accounts payable, related party
26,500
26,500
72,000
-
Deferred revenue
-244,638
608,913
-
-125,000
Accrued expenses
-73,153
98,665
-29,871
99,939
Operating lease liability
-13,536
-16,341
-16,049
187,408
Net cash provided by operating activities
-718,762
1,361,945
-289,192
-244,308
Purchase of property and equipment
-
-
107
-
Net cash used in investing activities
-
-
-107
-
Proceeds received on exercise of warrants
-
-
-
0
Proceeds from sale of common stock and exercise of warrants
-
-
14,800
-
Repayments on notes payable
79,809
54,360
72,513
85,071
Net cash used in financing activities
-79,809
-54,360
-72,513
-85,071
Net change in cash and cash equivalents
-798,571
1,307,585
-361,812
-329,379
Cash and cash equivalents at beginning of period
2,922,318
1,614,733
1,976,545
2,395,405
Cash and cash equivalents at end of period
2,123,747
2,922,318
1,614,733
1,976,545
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
SYRA Cash Flow Sankey Diagram
Sankey diagram visualizing SYRA cash flow for the period
Net change in cash
and cash...
-$798,571
(-792.45%↓ Y/Y)
Net income (loss)
$250,242
(146.70%↑ Y/Y)
Other current assets
-$72,170
(54.32%↑ Y/Y)
Accounts payable,
related party
$26,500
Stock-based compensation
$21,095
(-60.98%↓ Y/Y)
Right-of-use asset
-$13,536
(95.11%↑ Y/Y)
Depreciation
$741
(-94.20%↓ Y/Y)
Net cash provided by
operating activities
-$718,762
(-938.17%↓ Y/Y)
Net cash used in
financing activities
-$79,809
(54.46%↑ Y/Y)
Canceled cashflow
$384,284
Accounts receivable
$600,891
(192.36%↑ Y/Y)
Deferred revenue
-$244,638
(-197.86%↓ Y/Y)
Repayments on notes payable
$79,809
(-58.00%↓ Y/Y)
Accounts payable
-$170,828
(-137.51%↓ Y/Y)
Accrued expenses
-$73,153
(30.75%↑ Y/Y)
Operating lease liability
-$13,536
(95.11%↑ Y/Y)
Buy us a coffee
Syra Health Corp (SYRA)
Syra Health Corp (SYRA)